What companies are AKTX's competitors?

Akari Therapeutics, Plc (AKTX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does AKTX compare to its peers?

The peer comparison table on this page shows Akari Therapeutics, Plc (AKTX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does AKTX operate in?

Akari Therapeutics, Plc (AKTX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

AKTX

Akari Therapeutics, Plc

NASDAQ·Biotechnology · Healthcare

$9.10$1.23+15.63%

Pre-market·$9.41+3.41%

Market cap$10.42M·Market closed·Aug 26 8:00 PM UTC

Frequently Asked Questions About AKTX

What companies are AKTX's competitors?: Akari Therapeutics, Plc (AKTX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does AKTX compare to its peers?: The peer comparison table on this page shows Akari Therapeutics, Plc (AKTX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does AKTX operate in?: Akari Therapeutics, Plc (AKTX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

AKTX

Akari Therapeutics, Plc

NASDAQ·Biotechnology · Healthcare

$9.10$1.23+15.63%

Pre-market·$9.41+3.41%

Market cap$10.42M·Market closed·Aug 26 8:00 PM UTC

Peers


REVB	Revelation Biosciences, Inc.	$0.96	$3.7M
DRMA	Dermata Therapeutics, Inc.	$1.61	$1.1M
CDT	CDT Equity Inc.	$1.89	$918.2K
XAGE	Longevity Health Holdings Inc.	$0.28	$396.0K
PPBT	Purple Biotech Ltd.	$1.73	$238.9K
PBM	Psyence Biomedical Ltd.	$4.32	$82.2K
VINC	Vincerx Pharma, Inc.	$0.01	$66.5K
SYRS	Syros Pharmaceuticals, Inc.	$0.00	$2.7K
MSPR	MSP Recovery, Inc.	$0.00	$1.4K
VRPX	Virpax Pharmaceuticals, Inc.	$0.00	$249.0

Frequently Asked Questions About AKTX

What companies are AKTX's competitors?: Akari Therapeutics, Plc (AKTX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does AKTX compare to its peers?: The peer comparison table on this page shows Akari Therapeutics, Plc (AKTX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does AKTX operate in?: Akari Therapeutics, Plc (AKTX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.